Jamison Eaton & Wood’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Jamison Eaton & Wood’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$351K	Sell	3,751 -254	-6%	-$21.6K	0.1%	90
2014 Q4	$356K	Sell	4,005 -3,975	-50%	-$290K	0.1%	92
2014 Q3	$551K	Hold	7,980	–	–	0.15%	78
2014 Q2	$458K	Hold	7,980	–	–	0.13%	91
2014 Q1	$316K	Sell	7,980 -1,906	-19%	-$81.6K	0.09%	95
2013 Q4	$415K	Buy	9,886 +4,067	+70%	+$118K	0.11%	93
2013 Q3	$174K	Buy	5,819 +475	+9%	+$16.6K	0.05%	112
2013 Q2	$283K	Buy	+5,344	New	+$234K	0.08%	98

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Jamison Eaton & Wood's MACK Position: Q1 2015 in Review

Jamison Eaton & Wood reduced its Merrimack Pharmaceuticals, Inc. (MACK) stake by 6.3% in Q1 2015, selling an estimated $21.6K and leaving 3,751 shares worth $351K. The position accounts for 0.1% of the portfolio, ranked #90.

Jamison Eaton & Wood first reported a position in MACK in Q2 2013 and has held it in 8 quarters since. The position peaked at $551K in Q3 2014. 152 funds tracked by Wall St. Rank hold MACK as of Q1 2015.

Jamison Eaton & Wood held 3,751 shares of Merrimack Pharmaceuticals, Inc. worth $351K as of Q1 2015.
Jamison Eaton & Wood sold 254 Merrimack Pharmaceuticals, Inc. shares in Q1 2015, an estimated $21.6K.
Merrimack Pharmaceuticals, Inc. made up 0.1% of Jamison Eaton & Wood's portfolio in Q1 2015, its #90 holding.
Jamison Eaton & Wood first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and has held it in 8 quarters since.
Jamison Eaton & Wood's Merrimack Pharmaceuticals, Inc. position peaked at $551K in Q3 2014.
152 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2015.

Based on Jamison Eaton & Wood's 13F filing for Q1 2015, filed 30 Apr 2015.